RAPT Therapeutics to Participate in Multiple Upcoming Investor Conferences

Rhea-AI Summary

RAPT Therapeutics (NASDAQ: RAPT), a clinical-stage biopharmaceutical company specializing in immunology-based therapies, has announced its participation in four major investor conferences in September 2025.

The company will present at the Wells Fargo Healthcare Conference (Sept 3), Cantor Global Healthcare Conference (Sept 4), H.C. Wainwright Global Investment Conference (Sept 9), and Stifel Virtual Immunology & Inflammation Forum (Sept 15). All presentations will be accessible via webcast on the company's investor relations website.

SOUTH SAN FRANCISCO, Calif., Aug. 27, 2025 (GLOBE NEWSWIRE) -- RAPT Therapeutics, Inc. (Nasdaq: RAPT), a clinical-stage immunology-based biopharmaceutical company focused on discovering, developing and commercializing novel therapies for patients living with inflammatory and immunological diseases, today announced that members of the RAPT management team will participate in the following investor conferences in September:

• 2025 Wells Fargo Healthcare Conference – Fireside chat on Wednesday, September 3, 2025 at 12:45 p.m. ET

• Cantor Global Healthcare Conference 2025 – Fireside chat on Thursday, September 4, 2025 at 1:00 p.m. ET

• H.C. Wainwright 27th Annual Global Investment Conference – Fireside chat on Tuesday, September 9, 2025 at 9:00 a.m. ET

• Stifel 2025 Virtual Immunology & Inflammation Forum – Presentation on Monday, September 15, 2025 at 9:30 a.m. ET

To access the live webcasts or subsequent archived recordings of the fireside chats and presentation, please visit the RAPT Therapeutics website at https://investors.rapt.com/events-and-presentations.

About RAPT Therapeutics, Inc.
RAPT is a clinical-stage immunology-based biopharmaceutical company focused on discovering, developing and commercializing novel therapies for patients living with inflammatory and immunological diseases. Utilizing our deep and proprietary expertise in immunology, we develop novel therapies that are designed to modulate the critical immune responses underlying these diseases.

RAPT Investor Contact:
Sylvia Wheeler
swheeler@wheelhouselsa.com

RAPT Media Contact:
Aljanae Reynolds
areynolds@wheelhouselsa.com

FAQ

When is RAPT Therapeutics presenting at the Wells Fargo Healthcare Conference 2025?

RAPT Therapeutics will participate in a fireside chat at the Wells Fargo Healthcare Conference on Wednesday, September 3, 2025 at 12:45 p.m. ET.

How can investors access RAPT Therapeutics' conference presentations in September 2025?

Investors can access live webcasts and archived recordings of all presentations through RAPT Therapeutics' website at https://investors.rapt.com/events-and-presentations.

Which investor conferences will RAPT Therapeutics attend in September 2025?

RAPT will attend four conferences: Wells Fargo Healthcare Conference, Cantor Global Healthcare Conference, H.C. Wainwright Global Investment Conference, and Stifel Virtual Immunology & Inflammation Forum.

What time is RAPT Therapeutics presenting at the Stifel 2025 Virtual Immunology & Inflammation Forum?

RAPT Therapeutics will present at the Stifel Virtual Immunology & Inflammation Forum on Monday, September 15, 2025 at 9:30 a.m. ET.